British Journal of Cancer

Nme1 and Nme2 genes exert metastasis-suppressor activities in a genetically engineered mouse model of UV-induced melanoma.  124:161-165. 2021

Comment on “The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial”.  122:927-928. 2020

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.  118:213-223. 2018

Reply to 'Comment on 'Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: An individual-level cohort study'.  117:e7. 2017

Mammography service screening and breast cancer mortality in New Zealand: A National Cohort Study 1999-2011.  116:828-839. 2017

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK.  116:609-619. 2017

Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.  117:1303-1313. 2017

Dairy, calcium, Vitamin D and ovarian cancer risk in African-American women.  115:1122-1130. 2016

Analgesic medication use and risk of epithelial ovarian cancer in African American women.  114:819-825. 2016

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.  112:1951-1957. 2015

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.  111:1532-1541. 2014

Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.  110:2000-2010. 2014

Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.  110:946-957. 2014

Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer..  110:2054-2062. 2014

Cancer cell proliferation is inhibited by specific modulation frequencies.  106:307-313. 2012

DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma.  106:414-423. 2012

A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.  106:227-232. 2012

High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives.  105:1874-1884. 2011

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.  105:640-648. 2011

Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma.  105:523-533. 2011

Gene expression profiling of gliomas: Merging genomic and histopathological classification for personalised therapy.  104:545-553. 2011

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.  103:796-801. 2010

Hypoxia inducible factors in cancer stem cells.  102:789-795. 2010

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer.  99:1712-1717. 2008

Smad7 induces hepatic metastasis in colorectal cancer.  99:957-965. 2008

Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.  96:1480-1483. 2007

HIF and fumarate hydratase in renal cancer.  96:403-407. 2007

Differential proteomic alterations between localised and metastatic prostate cancer.  95:425-430. 2006

Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells.  93:1157-1167. 2005

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.  92:2266-2277. 2005

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.  90:1244-1251. 2004

Establishing a tumour bank: Banking, informatics and ethics.  90:1115-1119. 2004

Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.  87:1379-1385. 2002

Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene.  82:459-466. 2000

The interaction of buthionine sulphoximide (BSO) and the topoisomerase I inhibitor CPT-11.  74. 1996

Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women.  71:647-650. 1995

Epidemiological characteristics of Kaposi’s sarcoma prior to the AIDS epidemic.  70:674-676. 1994

Combination versus sequential single agent chemotherapy in advanced breast cancer: Associations with metastatic sites and long-term survival.  59:227-230. 1989

Sensitivity of locally recurrent rat mammary tumour cell lines to syngeneic polymorphonuclear cell, macrophage and natural killer cell cytolysis.  58:746-752. 1988

Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining moloney sarcomas.  38:365-374. 1978